The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Comprehensive clinical development programs being initiated for each investigational candidate
The National Sickle Cell Anaemia Elimination Mission was launched on 1st July 2023 at Shahdol, Madhya Pradesh
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
The establishment of the facility demonstrates the company's commitment to delivering differentiated solutions to gynecology and pediatrics challenges
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cell
The product will be manufactured at Lupin's Pithampur facility in India
Express Scripts to add Zepbound to National Preferred Formulary
Late-stage Fabhalta development program ongoing in multiple complement-mediated conditions
Methylene blue is a cationic thiazine dye that necessitates specialised capabilities and expertise to develop and manufacture the product
Subscribe To Our Newsletter & Stay Updated
